People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Deep Blue Medical Advances, Inc. | — | Biotechnology | Series A | $18.1M | $15.5M | 2017 |
| TrackX Technology, Inc. | — | Biotechnology | Series A | $10.9M | $150.3M | 2016 |
| NeurOp, Inc. | — | Biotechnology | Pre-Seed | $155K | $8.6M | 2014 |
Robert Bonczek at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Bonczek on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Isaacs | 2 | 2 |
| Ken Gall | 1 | 4 |
| William Perry | 1 | 3 |
| Michael Bates | 1 | 3 |
| Neil Meyer | 1 | 2 |
| Brent Duncan | 1 | 2 |
| Rick Simmons | 1 | 2 |
| Tony Recupero | 1 | 1 |
| Raymond Dingledine | 1 | 1 |
| James McNamara | 1 | 1 |
| Dennis Liotta | 1 | 1 |
| George Koszalka | 1 | 1 |
| Howard Levinson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.